Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
29.43
+0.50 (1.73%)
Aug 21, 2026, 4:00 PM EDT - Market closed

Maze Therapeutics Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Truist Financial
Truist Financial
Buy
Maintains
$64
BuyMaintains$64+117.47%Aug 13, 2026
Wedbush
Wedbush
Buy
Maintains
$48
BuyMaintains$48+63.10%Aug 12, 2026
BTIG
BTIG
Buy
Maintains
$46
BuyMaintains$46+56.30%Aug 12, 2026
Wells Fargo
Wells Fargo
Buy
Reiterates
$55
BuyReiterates$55+86.88%Aug 12, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Maintains
$110
BuyMaintains$110+273.77%Aug 12, 2026
LifeSci Capital
LifeSci Capital
Buy
Maintains
$57
BuyMaintains$57+93.68%Aug 12, 2026
Mizuho Securities
Mizuho Securities
Buy
Maintains
$97
BuyMaintains$97+229.60%Jun 23, 2026
J.P. Morgan
J.P. Morgan
Buy
Maintains
$58$53
BuyMaintains$58$53+80.09%May 23, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.